Which dialysis method works best for ICU kidney failure? a Head-to-Head test

NCT ID NCT06032884

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial compares two ways of filtering blood in critically ill patients with severe acute kidney injury: intermittent hemodialysis (done in sessions) and continuous renal replacement therapy (done non-stop). The goal is to see if the intermittent method is just as good as the continuous one in preventing death, lasting kidney damage, or the need for ongoing dialysis at 90 days. About 1,000 ICU adults on breathing support or blood pressure medication will be randomly assigned to one of the two methods. The study aims to help doctors choose the best dialysis approach for these very sick patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Two dialysis procedures: intermittent hemodialysis (IHD) and continuous renal replacement therapy (CRRT)
What this could lead to
If intermittent hemodialysis proves as effective as continuous therapy, it could offer a simpler, more flexible treatment option for ICU patients with severe kidney injury.
What could go wrong
The trial is large but still experimental; results may not show a clear difference, and both methods carry risks like low blood pressure or clotting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • c 001 Avicenne Service de réanimation médico chirurgicale

    Bobigny, Bobigny, 93000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.